Insilico Medicine: title card of the Inside China AI company profile

Insilico Medicine: An AI-Designed Lung Drug Reaches Phase III, With Europe’s Drugmakers Among Its Clients

Insilico Medicine’s AI-designed drug rentosertib is in Phase III in China. Servier and Menarini are among its[…]

Insilico Medicine: title card of the Inside China AI company profile

Insilico Medicine: KI-entwickeltes Lungenmedikament erreicht Phase III – Europas Pharmakonzerne unter den Kunden

Insilico Medicines KI-entwickeltes Medikament Rentosertib befindet sich in China in Phase III. Servier und Menarini zählen zu[…]